Use of a molecular classifier to identify usual interstitial pneumonia in conventional transbronchial lung biopsy samples: a prospective validation study

Ganesh Raghu(University of Washington), Fernando J. Martínez(University of Massachusetts Chan Medical School), Kevin R. Flaherty(University of Michigan), Jonathan H. Chung(National Jewish Health), David A. Lynch(McMaster University), Lars Hagmeyer(Krankenhaus Bethanien), Amy Hajari Case(The Ocean Cleanup), Brandon T. Larsen(Mayo Clinic in Arizona), Kevin M. Brown(National Cancer Institute), Jeffrey L. Myers(University of Michigan), David J. Lederer(Regeneron (United States)), P. Sean Walsh(Veracyte (United States)), Steven D. Nathan(Inova Fairfax Hospital), Thomas V. Colby(Mayo Clinic in Arizona), Lori Lofaro(Veracyte (United States)), Murali Ramaswamy(University of Iowa), Steve D. Groshong(National Jewish Health), Hannah Neville(Veracyte (United States)), Jing Huang(Veracyte (United States)), Sadia Benzaquen(University of Cincinnati), John R. Davis(Saint Luke's Hospital), Giulia C. Kennedy(Veracyte (United States)), Karel Calero(University of South Florida), Daniel G. Pankratz(Veracyte (United States)), Yoonha Choi(Ewha Womans University), Umair Gauhar(University of Louisville), Neil M. Barth(Veracyte (United States)), Mark P. Steele(Vanderbilt University), Gerard J. Criner(Temple University Hospital)

The Lancet Respiratory Medicine

April 1, 2019

Cited by 161

|European Respiratory Journal|2004|4.4k

|American Journal of Respiratory and Critical Care Medicine|2013|4.3k

|American Journal of Respiratory and Critical Care Medicine|2018|4.1k

|New England Journal of Medicine|2020|2.4k

|New England Journal of Medicine|2019|2.3k

Related Papers